Applications of iPSC-derived beta cells from patients with diabetes
Summary: Improved stem cell-derived pancreatic islet (SC-islet) differentiation protocols robustly generate insulin-secreting β cells from patient induced pluripotent stem cells (iPSCs). These advances are enabling in vitro disease modeling studies and the development of an autologous diabetes cell...
Main Authors: | Kristina G. Maxwell, Jeffrey R. Millman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Cell Reports Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666379121000549 |
Similar Items
-
Generation and validation of APOE knockout human iPSC-derived cerebral organoids
by: Yuka A. Martens, et al.
Published: (2021-06-01) -
Editorial: Understanding human biology with iPSC derived cell types in the Era of CRISPR technology
by: Huinan Li, et al.
Published: (2023-12-01) -
Generation of a CHIP isogenic human iPSC-derived cortical neuron model for functional proteomics
by: Catarina Dias, et al.
Published: (2022-06-01) -
Aberrant Splicing of <i>INS</i> Impairs Beta-Cell Differentiation and Proliferation by ER Stress in the Isogenic iPSC Model of Neonatal Diabetes
by: Alexandra V. Panova, et al.
Published: (2022-08-01) -
Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes
by: Diego Balboa, et al.
Published: (2018-11-01)